Alfred Gallegos

3.6k total citations · 2 hit papers
34 papers, 3.1k citations indexed

About

Alfred Gallegos is a scholar working on Molecular Biology, Biochemistry and Organic Chemistry. According to data from OpenAlex, Alfred Gallegos has authored 34 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 7 papers in Biochemistry and 6 papers in Organic Chemistry. Recurrent topics in Alfred Gallegos's work include Redox biology and oxidative stress (13 papers), Glutathione Transferases and Polymorphisms (8 papers) and Protein Kinase Regulation and GTPase Signaling (8 papers). Alfred Gallegos is often cited by papers focused on Redox biology and oxidative stress (13 papers), Glutathione Transferases and Polymorphisms (8 papers) and Protein Kinase Regulation and GTPase Signaling (8 papers). Alfred Gallegos collaborates with scholars based in United States, Sweden and Canada. Alfred Gallegos's co-authors include Garth Powis, Margareta Berggren, John R. Gasdaska, Mark R. Haussler, Margareta Berggren, Rosanne Bonjouklian, Pamela Y. Gasdaska, Murray Korc, Gerald B. Grindey and Barry S. Komm and has published in prestigious journals such as Science, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

In The Last Decade

Alfred Gallegos

34 papers receiving 3.0k citations

Hit Papers

2 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Estrogen Binding, Receptor mRNA, and Biologic Response in Osteoblast-Like Osteosarcoma Cells

1988 667 citations Alfred Gallegos et al. profile →
Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase.

1994 611 citations Garth Powis, Rosanne Bonjouklian et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Alfred Gallegos United States	20	2.2k	471	450	316	249	34	3.1k
Meng‐Er Huang France	31	3.6k 1.6×	357 0.8×	520 1.2×	180 0.6×	98 0.4×	73	4.5k
Randall C. Schatzman United States	29	1.9k 0.8×	431 0.9×	310 0.7×	1.5k 4.9×	228 0.9×	42	4.7k
Kiyoshi Nose Japan	38	3.0k 1.3×	525 1.1×	400 0.9×	205 0.6×	107 0.4×	121	4.5k
John Woods United States	28	1.7k 0.8×	502 1.1×	331 0.7×	188 0.6×	74 0.3×	41	3.5k
Kurt M. Bohren United States	31	1.9k 0.9×	244 0.5×	176 0.4×	93 0.3×	219 0.9×	54	3.6k
Réjean Ruel Canada	19	1.4k 0.6×	310 0.7×	141 0.3×	98 0.3×	469 1.9×	32	2.4k
David Brankow United States	19	1.6k 0.7×	659 1.4×	332 0.7×	85 0.3×	81 0.3×	24	3.0k
Christoph Schächtele Germany	32	2.4k 1.1×	619 1.3×	127 0.3×	106 0.3×	984 4.0×	77	4.3k
Patricio Aller Spain	30	1.7k 0.7×	384 0.8×	166 0.4×	224 0.7×	197 0.8×	82	2.5k
Sang‐Gu Hwang South Korea	38	2.4k 1.1×	913 1.9×	200 0.4×	60 0.2×	96 0.4×	123	3.9k

Countries citing papers authored by Alfred Gallegos

Since Specialization

Citations

This map shows the geographic impact of Alfred Gallegos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alfred Gallegos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alfred Gallegos more than expected).

Fields of papers citing papers by Alfred Gallegos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alfred Gallegos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alfred Gallegos. The network helps show where Alfred Gallegos may publish in the future.

Co-authorship network of co-authors of Alfred Gallegos

This figure shows the co-authorship network connecting the top 25 collaborators of Alfred Gallegos. A scholar is included among the top collaborators of Alfred Gallegos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alfred Gallegos. Alfred Gallegos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Weterings, Eric, Alfred Gallegos, Laurence Cooke, et al.. (2016). A novel small molecule inhibitor of the DNA repair protein Ku70/80. DNA repair. 43. 98–106. 58 indexed citations

2.

Cohen, Jennifer D., et al.. (2011). cAMP-Dependent Cytosolic Mislocalization of p27kip-Cyclin D1 During Quinol-Thioether–Induced Tuberous Sclerosis Renal Cell Carcinoma. Toxicological Sciences. 122(2). 361–371. 9 indexed citations

3.

Kong, Weixi, Robert K. Kuester, Alfred Gallegos, & I.G. Sipes. (2011). Induction of DNA damage in human urothelial cells by the brominated flame retardant 2,2-bis(bromomethyl)-1,3-propanediol: Role of oxidative stress. Toxicology. 290(2-3). 271–277. 12 indexed citations

4.

Baker, Amanda F., Mei Yee Koh, Ryan Williams, et al.. (2008). Identification of Thioredoxin-Interacting Protein 1 as a Hypoxia-Inducible Factor 1α-Induced Gene in Pancreatic Cancer. Pancreas. 36(2). 178–186. 45 indexed citations

5.

Bhattacharyya, A. K., Alfred Gallegos, Haiyan Cui, et al.. (2003). Increased expression of thioredoxin-1 in human colorectal cancer is associated with decreased patient survival. Journal of Laboratory and Clinical Medicine. 142(1). 46–51. 185 indexed citations

6.

Berggren, Margareta, Bryan Husbeck, Betty K. Samulitis, et al.. (2001). Thioredoxin Peroxidase-1 (peroxiredoxin-1) Is Increased in Thioredoxin-1 Transfected Cells and Results in Enhanced Protection against Apoptosis Caused by Hydrogen Peroxide but Not by Other Agents Including Dexamethasone, Etoposide, and Doxorubicin. Archives of Biochemistry and Biophysics. 392(1). 103–109. 100 indexed citations

7.

Grogan, Thomas M., R Zeheb, William Bellamy, et al.. (2000). Thioredoxin, a putative oncogene product,is overexpressed in gastric carcinoma and associated with increased proliferation and increased cell survival. Human Pathology. 31(4). 475–481. 163 indexed citations

8.

Yeates, Laura C., Alfred Gallegos, Alan P. Kozikowski, & Garth Powis. (2000). Down regulation of the expression of the p110, p85 and p55 subunits of phosphatidylinositol 3-kinase during colon cancer cell anchorage-independent growth.. PubMed. 19(5B). 4171–6. 6 indexed citations

9.

Freemerman, Alex J., Alfred Gallegos, & Garth Powis. (1999). Nuclear factor kappaB transactivation is increased but is not involved in the proliferative effects of thioredoxin overexpression in MCF-7 breast cancer cells.. PubMed. 59(16). 4090–4. 46 indexed citations

10.

Qiao, Lixin, Fajun Nan, Mark W. Kunkel, et al.. (1998). 3-Deoxy-d-myo-inositol 1-Phosphate, 1-Phosphonate, and Ether Lipid Analogues as Inhibitors of Phosphatidylinositol-3-kinase Signaling and Cancer Cell Growth. Journal of Medicinal Chemistry. 41(18). 3303–3306. 43 indexed citations

11.

Berggren, Margareta, Alfred Gallegos, John R. Gasdaska, & Garth Powis. (1998). Cellular thioredoxin reductase activity is regulated by selenium.. PubMed. 17(5A). 3377–80. 58 indexed citations

12.

Dvořáková, Kateřina, Robert T. Dorr, Alfred Gallegos, Thomas D. McClure, & Garth Powis. (1997). Pharmacokinetic studies of the herbicide and antitumor compound oryzalin in mice. Journal of Chromatography B Biomedical Sciences and Applications. 696(2). 275–281. 7 indexed citations

13.

Berggren, Margareta, Alfred Gallegos, John R. Gasdaska, et al.. (1997). Thioredoxin and thioredoxin reductase gene expression in human tumors and cell lines, and the effects of serum stimulation and hypoxia.. PubMed. 16(6B). 3459–66. 263 indexed citations

14.

Gasdaska, Pamela Y., et al.. (1996). Human Thioredoxin Reductase Gene Localization to Chromosomal Position 12q23–q24.1 and mRNA Distribution in Human Tissue. Genomics. 37(2). 257–259. 35 indexed citations

15.

Powis, Garth, Pamela Y. Gasdaska, Alfred Gallegos, Kyle W. Sherrill, & Daniel Goodman. (1995). Over-expression of DT-diaphorase in transfected NIH 3T3 cells does not lead to increased anticancer quinone drug sensitivity: a questionable role for the enzyme as a target for bioreductively activated anticancer drugs.. PubMed. 15(4). 1141–5. 33 indexed citations

16.

Powis, Garth, Alfred Gallegos, Robert T. Abraham, et al.. (1994). Increased intracellular Ca2+ signaling caused by the antitumor agent helenalin and its analogues. Cancer Chemotherapy and Pharmacology. 34(4). 344–350. 13 indexed citations

17.

Kozikowski, Alan P., Garth Powis, Abdul H. Fauq, Werner Tückmantel, & Alfred Gallegos. (1994). Synthesis and Biological Activity of the D-3-Deoxy-3-fluoro and D-3-Chloro-3-deoxy Analogs of Phosphatidylinositol. The Journal of Organic Chemistry. 59(5). 963–971. 15 indexed citations

18.

Oblong, John E., et al.. (1994). Reversible inhibition of human thioredoxin reductase activity by cytotoxic alkyl 2-imidazolyl disulfide analogues. Cancer Chemotherapy and Pharmacology. 34(5). 434–438. 2 indexed citations

19.

Brunn, G.J., Abdul H. Fauq, Sek C. Chow, et al.. (1994). Cellular pharmacology ofd-3-azido-3-deoxy-myo-inositol, an inhibitor of phosphatidylinositol signaling having antiproliferative activity. Cancer Chemotherapy and Pharmacology. 35(1). 71–79. 13 indexed citations

20.

Oblong, John E., et al.. (1994). Reversible inhibition of human thioredoxin reductase activity by cytotoxic alkyl 2-imidazolyl disulfide analogues. Cancer Chemotherapy and Pharmacology. 34(5). 434–438. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact